Literature DB >> 31583961

Do State Opioid Policies Influence Nonprofit Hospitals' Decisions to Address Substance Abuse in Their Communities?

Berkeley Franz1, Cory E Cronin1, Daniel Skinner1, José A Pagán2.   

Abstract

The U.S. epidemic of opioid abuse calls for broad collaboration between a wide range of health care institutions and the various levels of government. Through the community benefit programs they provide, nonprofit hospitals are well positioned to be key partners in local efforts. Although substance abuse appears on approximately 90% of the most recent community health needs assessments completed by hospitals, many hospitals are not addressing substance abuse in their programmatic efforts. Given wide state variation in policies to combat opioid abuse, we assess whether state leadership to address the opioid crisis influences hospital decisions to invest in substance abuse programs. Our findings suggest that several key state policies are related to hospital investments in substance abuse initiatives. To capitalize on the community benefit responsibilities of local hospitals, policies that provide specific direction for and engagement with local hospitals may increase cooperation and investments to address substance abuse.

Entities:  

Keywords:  community health; hospitals; nonprofit; opioids; policy

Year:  2019        PMID: 31583961     DOI: 10.1177/1077558719880090

Source DB:  PubMed          Journal:  Med Care Res Rev        ISSN: 1077-5587            Impact factor:   3.929


  2 in total

1.  Nonprofit Hospital Community Benefits: Collaboration With Local Health Departments to Address the Drug Epidemic.

Authors:  Tatiane Santos; Richard C Lindrooth
Journal:  Med Care       Date:  2021-09-01       Impact factor: 3.178

2.  Are Children's Hospitals Unique in the Community Benefits They Provide? Exploring Decisions to Prioritize Community Health Needs Among U.S. Children's and General Hospitals.

Authors:  Berkeley Franz; Cory E Cronin
Journal:  Front Public Health       Date:  2020-02-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.